Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


https://www.nature.com/articles/s41467-020-16455-7

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.